The European In Situ Hybridization Market is Projected to Grow at a CAGR of 11.0% till 2019 - A Report by MicroMarket Monitor

Share Article

Initiatives taken by the FDA to provide better personalized healthcare facilities propels the growth of the European In Situ Hybridization market http://www.micromarketmonitor.com/market/europe-in-situ-hybridization-9224136513.html

MicroMarket Monitor

MicroMarket Monitor

Key Players in the European In Situ Hybridization market are Applied Spectral Imaging, Agilent Technologies, Abbott Laboratories, Life Technologies, Affymetrix.

The European In Situ Hybridization market accounted for $247.4 million in 2013, which is projected to grow at a CAGR of 11.0% from 2014 to 2019.

In-situ hybridization is used to locate specific nucleic acids sequences to identify specific mRNA species within sample cells or tissue that are morphologically preserved by hybridization. The ISH technique can be classified into two types-fluorescent in-situ hybridization (FISH) and chromogenic/colometric in-situ hybridization (CISH). The ISH technique is beneficial to treat breast cancer as ISH is more reliable in terms of qualitative as well as quantitative evaluation of the biomarker. Other than breast cancer, ISH-based companion diagnostics are also used to detect mutations in patients with gastric cancer.

Browse through the TOC of the European In Situ Hybridization Market report, to get an idea of the in-depth analysis provided. This also provides a glimpse of the segmentation of motion sensor market and is supported by various tables and figures.

http://www.micromarketmonitor.com/market/europe-in-situ-hybridization-9224136513.html

Early buyers will receive 10% customization on this report.

http://www.micromarketmonitor.com/contact/9224136513-request_for_customization.html

Regulatory bodies in the EU are encouraging the manufacturers to identify a large number of biomarkers and develop diagnostics tests with an aim to reduce the mortality rate of cancer patients by providing them with better targeted therapeutic drugs. According to Globocan data, in 2012, the number of cancer deaths was estimated to be 1,276,000 in the EU region. New regulations have been introduced that have the potential to increase the significance of the market.

http://www.micromarketmonitor.com/market/europe-in-situ-hybridization-9224136513.html

The incidence of breast cancer has been increasing in various countries due to changing reproduction patterns and lifestyles, mammography screening, increasing use of oral contraceptives, and increasing use of hormone replacement therapy in women. According to Globocan, in Europe, the incidence rate of breast cancer was the highest in 2012 (13.5%) that is expected to reach 20.0% by 2017. According to the OECD 2013 data, the healthcare expenditure in Spain was 9.3% of its GDP in 2011; this has encouraged the Spain National Health System to provide free health coverage and early detection of breast cancer. Spain has witnessed one of the lowest breast cancer mortality rates in 2014 among other European countries. These activities provide an opportunity for the development of ISH test for breast cancer in the European region.

Speak to Analyst @

http://www.micromarketmonitor.com/contact/9224136513-speak_to_analyst.html

The European In Situ Hybridization market is classified on the basis of geography, types, products, and geography. According to geographical segmentation, this market is categorized into regions such as the U.K., Germany, Italy, France, Spain and Rest of Europe.

In addition to this, the report also provides the market share, value chain analyses and market metrics including upcoming opportunities in this market. In addition, it presents a competitive landscape and company profiles of key players in the market including major companies of the market.

Related Reports :

Global DNA Microarray Market

A DNA microarray is a collection of microscopic DNA spots attached to a solid surface. It is a high throughput technology used to measure the expression levels of genes. Oligonucleotide-based arrays and complementary DNA chips are the technology segment of this market. Oligonucleotide (oDNA) microarrays are constructed by spotting short DNA oligonucleotides on a silicon wafer or glass array using either inkjet print technology or photolithography. Complementary DNA chips are constructed by immobilizing it onto a solid surface, such as glass, using either inkjet print or mechanical microspotting technology.

The DNA microarray market report analyzes its driving forces, new opportunities, winning imperatives, and burning issues. The restraints, challenges, and regulatory affairs relevant to the market have also been discussed. The DNA microarray ecosystem, Porter’s Five Forces Analysis, product lifecycles and market chasm analysis are also in the scope of the market study. Government-funded research in gene-related diagnostics and drug development fuels the market growth.

http://www.micromarketmonitor.com/market-report/dna-microarray-reports-5177428198.html

About MicroMarket Monitor :

MicroMarket Monitor identifies and attends to various unmet needs of different industrial verticals, which include value chain impact analysis. The company publishes about 12000 Market Research Reports on various Micro Markets across the world. The graphical nature and multidimensional analysis of these reports provide advanced Business Intelligence Tools to the clients in that particular target market.

Contact:
Mr. Chandrasekhar K.
5601 Bridge Street
Suite 300
Fort Worth, TX 76112
Tel: +1-888-502-0539
Email: sales(at)micromarketmonitor(dot)com
Connect with us on LinkedIn at http://www.linkedin.com/company/micromarketmonitor.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Mr. Chandrasekhar K.
@mmarketmonitor
Follow >
Micro Market Monitor
Like >
Follow us on
Visit website